Bay Area biotech company Synthego, raised $392M, forced into bankruptcy

4 randycupertino 2 5/19/2025, 10:59:02 PM sfgate.com ↗

Comments (2)

duxup · 12h ago
Biotech seems to historically require a lot of iterations / failures before breakthroughs happen.

I'm not sure the typical VC "startup" type expectations / speed really lends itself to that kind of business.

hoseyor · 12h ago
I wonder if that was private lending/credit. There seems to be a huge issue building in that unregulated space.